key: cord-0295482-3q8jhp9v
authors: Gychka, S. G.; Kuchyn, I. L.; Savchuk, T. V.; Nikolaienko, S. I.; Zhezhera, V. M.; Chermak, I. I.; Suzuki, Y. J.
title: Placental vascular remodeling in pregnant women with COVID-19
date: 2021-07-03
journal: nan
DOI: 10.1101/2021.07.01.21259860
sha: 8b4e6c0be6e7d4bb2443ecf3369ea88ddb6da479
doc_id: 295482
cord_uid: 3q8jhp9v

Severe acute respiratory syndrome coronavirus 2 has been causing the pandemic of coronavirus disease 2019 (COVID-19) that has so far resulted in over 180 million infections and nearly 4 million deaths. This respiratory virus uses angiotensin-converting enzyme 2 as a receptor to enter host cells, exhibiting a unique feature that affects various tissues in addition to the lungs. The present study reports that the placental arteries from women who gave birth to live full-term newborns while developing of COVID-19 during pregnancy exhibit severe vascular wall thickening and the occlusion of the vascular lumen. A morphometric analysis of the placental arteries stained with hematoxylin and eosin suggest a 2-fold increase in wall thickness and a 5-fold decrease in the lumen area. Immunohistochemistry with alpha-smooth muscle actin and Masson's trichrome staining showed that such placental vascular remodeling in COVID-19 is associated with smooth muscle proliferation and fibrosis. Placental vascular remodeling may represent a mechanism of the clinical problems associated with childbirth in COVID-19 patients.

Coronaviruses are positive-sense, single-stranded RNA viruses that often cause the common cold [1, 2] ; however, some coronaviruses can promote severe health problems.

Currently, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been causing the pandemic of coronavirus disease 2019 (COVID-19) [3, 4] . So far, over 180 million people have been infected with SARS-CoV-2, with nearly 4 million deaths worldwide, causing enormous health, economic, and sociological problems. SARS-CoV-2 enters host cells via the angiotensinconverting enzyme 2 (ACE2) receptor [5, 6] . While lung cells are the primary targets of this respiratory virus, causing acute respiratory distress syndrome [7, 8] , SARS-CoV-2 also affects other ACE2-expressing tissues including those of the cardiovascular system [4, 9, 10] .

COVID-19 is associated with increased neonatal and maternal morbidity and mortality [11] [12] [13] . However, the mechanism of the effects of COVID-19 on pregnant women is not understood. Such information should help develop therapeutic strategies to reduce the mortality and morbidity associated with COVID-19.

The present study demonstrates that women who became infected with SARS-CoV-2 and developed COVID-19 symptoms during pregnancy exhibited severe vascular remodeling of the placental arteries as determined by histological examinations. Vascular remodeling is associated with increased smooth muscle cell proliferation and fibrosis. These mechanisms may explain how some neonates are affected by COVID-19.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 3, 2021. ; https://doi.org/10.1101/2021.07.01.21259860 doi: medRxiv preprint

Placental tissues were collected from 113 patients who gave birth to live full-term newborns in Ukraine. Among them, 85 patients were infected with SARS-CoV-2 and developed COVID-19 symptoms at 28 -36 weeks of pregnancy. For comparison purposes, we used placental tissues from 28 women who underwent live childbirth without contracting SARS-CoV-2 as determined by a PCR test. Ages of mothers, weeks of gestation when the child birth occurred, placenta weights, and Apgar scores are summarized in Table 1 . Clinical studies were approved by the regional committee for medical research ethics in Kiev, Ukraine and performed under the Declaration of Helsinki of 1975 revised in 2013 or comparable ethical standards. All the patients provided written informed consent.

Tissue samples were fixed overnight in 10% buffered formalin at room temperature. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 3, 2021. ; https://doi.org/10.1101/2021.07.01.21259860 doi: medRxiv preprint

For the morphometric analysis, IBM SPSS Statistics software version 22.0 was used for the statistical calculations. A Mann-Whitney U test was used to define statistical significance at p < 0.05. patients than in those without COVID-19 ( Fig. 2A) . These two values are significantly different (p < 0.01). The placental arterial lumen area was found to be significantly smaller (5-fold) in COVID-19 patients than in controls (p < 0.01, Fig. 2B ).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 3, 2021. ; https://doi.org/10.1101/2021.07.01.21259860 doi: medRxiv preprint

Masson's trichrome staining as shown in Fig. 3 shows that women who contracted COVID-19 during pregnancy exhibited severe fibrosis of vascular walls and perivascular space in semi-stem placenta villi.

Immunohistochemistry using a smooth muscle cell marker, α -smooth muscle actin, clearly indicated the dramatic increase in smooth muscle mass in the placental arteries of COVID-19 patients (panels D-F, Fig. 4 ) compared with controls without COVID-19 (panels A-C, Fig. 4 ). Given the substantial increase in the mass of smooth muscle, it is likely that the placental arteries of COVID-19 patients underwent smooth muscle cell proliferation.

The major finding of this study is that the arteries of the placentas of women who gave birth to live full-term newborns, but contracted COVID-19 during pregnancy, exhibited severe vascular remodeling.

The narrowing of the placental arterial lumen is expected to alter the blood flow between the mother and the fetus. In the population investigated in this study, despite the occurrence of severe placental vascular remodeling, COVID-19 did not significantly impacted the health of newborn children according to the evaluations of appearance, pulse, grimace, activity, and respiration as quantified by Apgar scores. However, in our participating hospitals in Ukraine, out of 250 births by women who contracted COVID-19 during pregnancy, 13 cases of antenatal fetal death occurred at the rate of 5.2% that is dramatically higher than the average of the general population. Further work should be performed to determine the impact of COVID-19 on pregnancy and the effects of placental vascular remodeling in the well being of the newborns and their development.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 3, 2021. In summary, the present study found that placental vascular walls thickened and the lumen narrowed in women who gave live birth but contracted COVID-19 during pregnancy. The smooth muscle proliferation and the collagen fiber deposition appear to play major roles in the development of placental vascular remodeling. Future investigations should aim to determine the role of SARS-CoV-2 spike protein-mediated cell growth signaling in the mechanism of placental vascular remodeling in COVID-19 patients. Elucidating such a mechanism should help provide new therapeutic targets to combat the SARS-CoV-2 infection and COVID-19 and prevent stillbirth and premature birth as well as alternations of child development.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 3, 2021. ; https://doi.org/10.1101/2021.07.01.21259860 doi: medRxiv preprint

This work was supported in part by the National Institutes of Health (grant numbers R21AI142649, R03AG059554, R03AA026516) to Y.J.S. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

None.

angiotensin-converting enzyme 2 COVID-19 coronavirus disease 2019 H&E hematoxylin and eosin SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 3, 2021. ; https://doi.org/10.1101/2021.07.01.21259860 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 3, 2021. ; https://doi.org/10.1101/2021.07.01.21259860 doi: medRxiv preprint Table 1 

With COVID-19

Ages of mothers (years) 30.2 ± 4.7 31.0 ± 4.9

Weeks of gestation (weeks) 39.7 ± 1.7 39.6 ± 4.9

Weight of placenta (grams) 523.1 ± 104.3 543.6 ± 131.1 Apgar 7.9 ± 0.4 7.7 ± 0.8 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 3, 2021. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 3, 2021. ; https://doi.org/10.1101/2021.07.01.21259860 doi: medRxiv preprint 1 4 (D-F) Immunohistochemisry images of three women who gave birth (at 40 weeks of gestation), but contracted COVID-19 at 28, 32, and 36 weeks of pregnancy. Magnification x200.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 3, 2021. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 3, 2021. ; https://doi.org/10.1101/2021.07.01.21259860 doi: medRxiv preprint Without COVID-19

With COVID-19 at 32 week With COVID-19 at 36 week . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 3, 2021. ; https://doi.org/10.1101/2021.07.01.21259860 doi: medRxiv preprint Without COVID-19

With COVID-19 at 32 week With COVID-19 at 36 week . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 3, 2021. ; https://doi.org/10.1101/2021.07.01.21259860 doi: medRxiv preprint

Epidemiology, genetic recombination, and pathogenesis of coronaviruses

The molecular biology of SARS coronavirus

A new coronavirus associated with human respiratory disease in China

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine